Dr. Bruce Leuchter is a Managing Director at PJT Partners where he provides capital markets and M&A advisory services to companies in the life sciences industry with a focus on the biotechnology sector. Dr. Leuchter is a physician by training and Neuropsychiatrist by specialty. He completed residency training in Neurology and Psychiatry at New York Presbyterian Hospital / Cornell Medical Center and is a Dipolmate of the American Board of Psychiatry and Neurology. Dr. Leuchter served as Director of Clinical Neuropsychiatry at Weill Medical College of Cornell University and maintains a faculty appointment of Clinical Assistant Professor of Psychiatry. Dr. Leuchter's financial services experience, prior to joining PJT Partners, includes roles in equity research and investment banking at Goldman Sachs and Credit Suisse, respectively. He joined Goldman Sachs in 2008 to spearhead a Global Investment Research initiative analyzing emerging biotechnology companies, and later joined Credit Suisse as an investment banker focused on the biotechnology sector. Given his background in neuroscience, he frequently advises companies developing technologies for diseases of the brain and nervous system. Dr. Leuchter co-founded Click Therapeutics, a digital medicine company which engineers, validates and commercializes digital therapeutics solutions to benefit people with unmet medical needs through cognitive and neurobehavioral modifications. He serves as a member of the Scientific Advisory Committee for the Daedelus Fund for Innovation, a seed technology development program at Weill Medical College of Cornell University created to foster and expedite the development of early-stage translational research projects.